| ACE-I Lowers the Risk for Renal Disease in Obese Patients - Medscape |
|
|
Medscape Among participants randomly assigned to receive placebo, obese patients had a substantially higher incidence rate of end-stage renal disease (ESRD) than overweight patients (24 vs 11 events/100 person-years) or those with normal BMI (10 events/100 |